• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.

作者信息

Qiu Shizheng, Zhang Yu, Wang Donghua, Hu Yang

机构信息

School of Life Science and Technology, Harbin Institute of Technology, N o. 2, Yikuang Street, Harbin, Nangang District 150001, China.

Department of Neurosurgery, Heilongjiang Province Land Reclamation Headquarters General Hospital, China.

出版信息

J Infect. 2021 Dec;83(6):709-737. doi: 10.1016/j.jinf.2021.08.045. Epub 2021 Sep 2.

DOI:10.1016/j.jinf.2021.08.045
PMID:34481830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8411593/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480f/8411593/c8087e920e50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480f/8411593/c8087e920e50/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/480f/8411593/c8087e920e50/gr1_lrg.jpg

相似文献

1
The high expression of SARS-CoV-2 cell receptors might lead to higher COVID-19 infection rates in cancer patients.新型冠状病毒2型（SARS-CoV-2）细胞受体的高表达可能导致癌症患者更高的新型冠状病毒肺炎（COVID-19）感染率。
J Infect. 2021 Dec;83(6):709-737. doi: 10.1016/j.jinf.2021.08.045. Epub 2021 Sep 2.
2
A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?一项关于 COVID-19 合并症的荟萃分析：哪些疾病会增加 SARS-CoV-2 感染的易感性？
Comput Biol Med. 2021 Mar;130:104219. doi: 10.1016/j.compbiomed.2021.104219. Epub 2021 Jan 16.
3
Ocular COVID-19: Eyes as a Reservoir to Conceal and Spread SARSCoV- 2.眼部分泌物或为新冠病毒藏身和传播的“温床”
Infect Disord Drug Targets. 2021;21(4):480-483. doi: 10.2174/1871526520999200729182242.
4
Preexisting and Post-COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer.癌症患者对 SARS-CoV-2 的预先存在和 COVID-19 后免疫反应。
Cancer Discov. 2021 Aug;11(8):1982-1995. doi: 10.1158/2159-8290.CD-21-0191. Epub 2021 May 19.
5
SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.SARS-CoV-2 激活肺上皮细胞促炎信号，导致 COVID-19 患者免疫失调。
EBioMedicine. 2021 Aug;70:103500. doi: 10.1016/j.ebiom.2021.103500. Epub 2021 Jul 23.
6
High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR.癌症患者出现 COVID-19 症状，无论 RT-PCR 是否检测到 SARS-COV-2，死亡率均较高。
Eur J Cancer. 2020 Aug;135:251-259. doi: 10.1016/j.ejca.2020.05.028. Epub 2020 Jun 7.
7
SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience.SARS-CoV-2 检测在无症状癌症患者治疗前后：单中心经验。
Curr Oncol. 2021 Jan 6;28(1):278-282. doi: 10.3390/curroncol28010032.
8
National cross-sectional survey of 1.14 million NHS staff SARS-CoV-2 serology tests: a comparison of NHS staff with regional community seroconversion rates.全国范围内对 114 万 NHS 员工进行的 SARS-CoV-2 血清学检测的横断面调查：NHS 员工与区域社区血清转化率的比较。
BMJ Open. 2021 Jul 13;11(7):e049703. doi: 10.1136/bmjopen-2021-049703.
9
Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study.伴有非重症 COVID-19 的肿瘤患者接受全身性抗癌治疗的安全性：一项队列研究。
BMC Cancer. 2021 May 20;21(1):578. doi: 10.1186/s12885-021-08349-8.
10
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.SARS-CoV-2 感染和接受免疫检查点抑制剂治疗的癌症患者的不良事件：一项观察性前瞻性研究。
J Immunother Cancer. 2021 Feb;9(2). doi: 10.1136/jitc-2020-001694.

引用本文的文献

1
Novel evidence revealed genetic association between COVID-19 infection, severity and endometrial cancer.新证据揭示了新冠病毒感染、严重程度与子宫内膜癌之间的基因关联。
J Infect. 2022 Jul;85(1):e1-e3. doi: 10.1016/j.jinf.2022.05.005. Epub 2022 May 10.
2
The high expression of key components of inflammasome and pyroptosis might lead to severe COVID-19 infection in cancer patients.炎症小体和细胞焦亡关键成分的高表达可能导致癌症患者发生严重的新冠病毒感染。
J Infect. 2022 Apr;84(4):e19-e21. doi: 10.1016/j.jinf.2022.01.043. Epub 2022 Feb 3.
3
Genetic variation associated with COVID-19 is also associated with endometrial cancer.
与新冠病毒肺炎相关的基因变异也与子宫内膜癌有关。
J Infect. 2022 May;84(5):e85-e86. doi: 10.1016/j.jinf.2022.01.026. Epub 2022 Jan 22.
4
The COVID-19 susceptibility of cancer patients might due to the high expression of SARS-CoV-2 required host factors.癌症患者对新冠病毒的易感性可能归因于新冠病毒所需宿主因子的高表达。
J Infect. 2022 Mar;84(3):418-467. doi: 10.1016/j.jinf.2021.12.011. Epub 2021 Dec 22.